Home » Stroke Management Market

Stroke Management Market

Stroke Management Market – Growth, Future Prospects, And Competitive Analysis, 2018-2026
Report Book

Published Date: May 2018
Category: Pharmaceuticals
Report ID: 59178
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

Stroke is predominantly observed among the geriatric population and is globally considered a major cause of death. The adoption of unhealthy lifestyle patterns, as well as alcohol and smoking addiction, have all contributed to an increase in stroke prevalence. As per the American Medical Association, around 40% of the geriatric population (aged 55 and above) in the U.S. suffers from a stroke. The World Health Organization estimates around 17 million deaths due to stroke annually. According to the Centers for Disease Control and Prevention, around 0.7 million individuals in the U.S. suffer from stroke each year. The rise in stroke prevalence drives the overall market growth. The stroke management market is analyzed by segmenting it by type of product, application, and geography. The products are further classified into diagnostic and therapeutic products.

The growing awareness among individuals and healthcare professionals plays an important role in the growth of this market. The rise in awareness has led to an increase in the diagnosis rate of stroke, which accounted for its maximum market share in 2017. With the rise in technological advancements and patients considering preventive diagnosis, the diagnostic segment would also attain the fastest CAGR during the forecast period. The availability of suitable treatment guidelines ensures appropriate treatment, thus catalyzing the overall stroke management market. The American Heart Association collaborated with the Heart Rhythm Society, the American Academy of Family Physicians, and the International Society for Heart and Lung Transplantation to develop guidelines that would aid physicians in the appropriate treatment of heart failure. These guidelines provide a foundation for appropriate cardiovascular care. However, high treatment costs and stringent government policies to approve new and advanced diagnostic technologies could interfere with the growth of this market.

Of the various geographical regions analyzed, North America held the largest market share in 2017. Asia Pacific is projected to grow with the fastest CAGR during the forecast period from 2018 to 2026. The North American market’s growth is predominantly driven by the rise in the prevalence of chronic diseases leading to cardiovascular risks, increased disposable income, a rise in healthcare expenditure, and constant investments in research and development.

The global stroke management market is segmented as follows:

By Product

  • Diagnostics
  • Computed Tomography Scan (CT Scan)
  • Magnetic Resonance Imaging (MRI)
  • Carotid Ultrasound
  • Cerebral Angiography
  • Electrocardiography
  • Echocardiography
  • Other diagnostics


  • Tissue Plasminogen Activator
  • Anticoagulant
  • Antiplatelet
  • Antihypertensive

By Application

  • Ischemic Stroke
  • Haemorrhagic Stroke

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

The global stroke management market comprises the following players: B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corp., Medtronic Plc., Bristol-Myers Squibb, Cardinal Health, Siemens Healthcare, GE Healthcare, Merck & Company, GlaxoSmithKline Plc.

This report offers the following:

  • A complete understanding of the global stroke management market
  • Market estimations and insights for the period from 2016 to 2026, with 2016 as the historical year and 2017 as the base year
  • The CAGR for the period from 2018 to 2026 with regards to the whole market and each segment considered has been incorporated in this report.
  • Qualitative information about market dynamic factors such as market drivers, challenges, and opportunities
  • An elaborative study on the competitive landscape and the profiling of the key industry leaders

Frequently Asked Questions:

What is the size of Stroke Management Market?

The market for Stroke Management Market is expected to reach US$ XX Mn by 2026.

What is the Stroke Management Market CAGR?

The Stroke Management Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Stroke Management Market?

The report is forecasted from 2018-2026.

What is the base year considered for Stroke Management Market?

The base year of this report is 2017.

Who are the major players in this market?

B. Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corp., Medtronic Plc., Bristol-Myers Squibb, Cardinal Health, Siemens Healthcare, GE Healthcare, Merck & Company, GlaxoSmithKline Plc. are some of the major players in the global market.

Download Sample Report

Have a question?

Market Research Analyst

Don’t settle for less – trust Ishika to help you find the best solution.

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 8085 89 5002


24/7 Research Support

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN